2359O Phase III THOR study: Results of erdafitinib (erda) vs pembrolizumab (pembro) in pretreated patients (pts) with advanced or metastatic urothelial cancer (muc) with select fibroblast growth factor receptor alterations (FGFRalt)

Siefker-Radtke A., Matsubara N., Park S., Huddart R., Burgess E., Özgüroğlu M., ...More

ANNALS OF ONCOLOGY, vol.34, pp.1, 2023 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 34
  • Publication Date: 2023
  • Doi Number: 10.1016/j.annonc.2023.09.1008
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Page Numbers: pp.1
  • Istanbul University-Cerrahpasa Affiliated: No